T. Rowe Price Associates’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $428K | Buy |
|
|||||
|
2022
Q2 | $118K | Buy |
|
|||||
|
2022
Q1 | $105K | Sell |
|
|||||
|
2021
Q4 | $94K | Sell |
|
|||||
|
2021
Q3 | $332K | Sell |
|
|||||
|
2021
Q2 | $469K | Buy |
|
|||||
|
2021
Q1 | $501K | Buy |
|
|||||
|
2020
Q4 | $378K | Buy |
|
|||||
|
2020
Q3 | $280K | Sell |
|
|||||
|
2020
Q2 | $441K | Buy |
|
|||||
|
2020
Q1 | $363K | Sell |
|
|||||
|
2019
Q4 | $8.49M | Sell |
|
|||||
|
2019
Q3 | $6.94M | Sell |
|
|||||
|
2019
Q2 | $10.8M | Buy |
|
|||||
|
2019
Q1 | $17.3M | Sell |
|
|||||
|
2018
Q4 | $13.3M | Buy |
|
|||||
|
2018
Q3 | $22.5M | Buy |
|
|||||
|
2018
Q2 | $24.3M | Buy |
|
|||||
|
2018
Q1 | $18.5M | Buy |
|
|||||
|
2017
Q4 | $19.6M | Buy |
|
|||||
|
2017
Q3 | $13.3M | Buy |
|
|||||
|
2017
Q2 | $12.2M | Sell |
|
|||||
|
2017
Q1 | $19.9M | Buy |
|
|||||
|
2016
Q4 | $1.01M | Buy |
|
|||||
|
2016
Q3 | $1.01M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $10.4M | Buy |
|